Infection with avian leukosis virus subgroup J (ALV-J) causes severe economic losses in the broiler industry by increasing mortality, producing tumors, and decreasing weight gain in chickens. The quantitation of ALV-J is difficult because of its failure to produce a cytopathic effect in cell culture systems and the nonspecificity of antigen-capture enzyme-linked immunosorbent assay (ELISA) tests. This study was performed to develop a quantitative competitive-reverse transcriptase-polymerase chain reaction (QC-RT-PCR) method based on coamplification of ALV-J genomic RNA and a known amount of a synthesized RNA competitor. The 369 bp RNA competitor was constructed by restriction enzyme treatment of an ALV-J specific 545 bp PCR product, ligation, transformation into Escherichia coli, and in vitro transcription. The competitor contained the same amplification primer annealing sites and sequence as the original viral RNA, except that it had a 176 bp internal deletion. Coamplified RT-PCR products were visualized by electrophoresis and ethidium bromide staining, and fluorescences were quantified using computer-assisted image analysis. The sensitivity of this new QC-RT-PCR method was 25 fg of viral RNA, and 10-fold dilutions were differentiable. This method allowed absolute and relative quantification of ALV-J RNA copy numbers and was simpler than previously published methods for ALV-J quantification.
eration of research on ALV-J viral pathogenesis. Similar to other viruses, tissue culture infective dose 50 (TCID 50 ) has been used to express the viral quantity for ALV-J. Because no observable cytopathic effect is produced by ALV-J infection, TCID 50 has previously been determined by serial dilution of a sample and by inoculating it into embryo fibroblasts form C/E chicken line to prevent growth of endogenous viruses. After 7-9 days incubation, viral growth in diluted samples is detected using an antigen-capture enzyme-linked immunosorbent assay (ELISA) for a group-specific p27 antigen. 9 This technique is time consuming, laborious, expensive, and very difficult to perform in some laboratories because of the lack of C/E cells.
Reverse transcriptase-polymerase chain reaction has been extensively used in qualitative and quantitative analyses of gene expression. Quantitative measurement of RNA levels in different samples requires the use of an internal control, endogenously expressed RNA, which is coamplified along with the target RNA(s) of interest. 10 Ubiquitously expressed genes coding for metabolic enzymes, ribosomal proteins, or translation elongation factors are widely used as internal controls. 10 The ideal internal control should be completely invariable in its level of expression. In addition, the abundance of the internal control RNA must be similar to that of the target RNA. 5 If the internal control and target templates are amplified by different primer pairs or differ significantly in sequence, size, or secondary structure, it is also necessary to control for differences in amplification efficiencies. 5 There is no known endogenous internal control that meets these criteria in some samples such as plasma. So to measure the quantity of the gene present in those samples, an exogenous control must be used. In competitive reverse transcriptase-polymerase chain reaction (RT-PCR), the exogenous control template is amplified by the same primers as the endogenous target, thus minimizing differences in amplification efficiency. 10, 14 Several ALV-J specific PCR systems have been developed and are widely used for both laboratory and field samples. 16 The current work was performed to develop a one-tube quantitative competitive (QC)-RT-PCR and to standardize and verify a newly developed technique by comparing it with the amounts of RNA measured using spectrophotometry of in vitro-transcribed standard control RNA.
Materials and methods
Virus sample. An ALV-J isolate, ADOL-7501, a was propagated in primary or secondary C/E chicken embryo fibroblasts (CEFs) b grown at 37 C. The virus was cultivated for 8 days in the monolayer of C/E CEFs. After freezing and thawing (3ϫ) of the infected-cell culture, p27 gs-antigen was detected using a commercial ag-ELISA kit. c Two samples with 10 4 and 10 5 TCID 50 , determined as previously described, 9 were selected for future QC-RT-PCR analysis.
RNA extraction. Total RNAs were extracted from 250 l of each cell lysate described above using a commercial reagent d according to the manufacturer's recommendations. Each RNA sample was suspended in 20 l of diethyl pyrocarbonate (DEPC)-treated water and stored at Ϫ80 C until used.
Reverse transcriptase-polymerase chain reaction. Onetube RT-PCR was carried out using a Titan One-tube RT-PCR system e according to the manufacturer's recommendations. The oligonucleotides used in the RT-PCR reaction were primers H5 (5Ј-GGATGAGGTGACTAAGAAAG-3Ј) and H7 (5Ј-CGAACCAAAGGTAACACACG-5Ј). 16 The amplifications were performed in a thermocycler. f The program consisted of reverse transcription at 42 C for 45 min, 95 C for 5 min, and 35 identical cycles of denaturation (94 C for 30 sec), annealing (52 C for 30 sec), extension (72 C for 1 min), followed by an extra 5 min (72 C) at the end of the last cycle. The reaction component was added in reaction tubes to a final volume of 25 l. Final reaction conditions were 0.5 l of enzyme mix and 5 l 5ϫ dilution buffer provided in the Titan One-tube RT-PCR system, 2 mM MgCl 2 , 0.25 mM deoxynucleoside triphosphate (dNTP) mix, 5 M of primers H5 and H7, 20 U ribonuclease (RNase) inhibitor, 2.5 mM dithiothreitol (DTT), and 1 l of template.
Preparation of competitor RNA. The same isolate previously described, ALV-J (ADOL-7501), was propagated in C/ E CEFs, and total RNA was prepared from the infected-cell culture lysates as described above. Reverse transcriptasepolymerase chain reaction amplification with the primers H5 and H7 (H5/H7) was carried out as described above and produced a cDNA amplicon of 545 bp, including portions of the integrase and gp85 genes of the ALV-J genome. The amplicon was analyzed using gel electrophoresis (1.5% lowmelting point agarose and Tris acetate buffer system) and visualized by ethidium bromide staining. A single band of amplicon, corresponding to the 545 bp complementary DNA, was purified from the agarose gel using a QiaQuick Gel extraction kit g according to the manufacturer's instructions. The purified amplicon was aliquoted into 2 tubes and treated with Taq I h and Aci I h , respectively. Digested products of both tubes were separated by gel electrophoresis and ethidium bromide staining. The 5Ј-end fragment of Taq I treated and the 3Ј-end fragment of Aci I treated were purified from the gel as described above and religated with bacteriophage T4 DNA ligase h using a thermocycler f programmed to lower the temperature gradually from 22 C to 4 C overnight. The ligation product (10 l) was diluted 10-fold in ddH 2 O, and 2 l was used as a template for PCR amplification with H5/H7 to check the ligation reaction. After gel electrophoresis, the expected product (369 bp) was purified from the gel using the commercial kit described above and cloned into the pGEM-T Easy vector system, i according to the manufacturer's instructions. A competent JM109 highefficiency Escherichia coli strain i was transformed with the recombinant plasmid and plated on Luria Broth (LB) plates containing ampicillin (100 g/ml), 0.5 mM isopropyl-L-thio-␤-galactoside, and X-gal (80 mg/ml). After 18 hr of incubation at 37 C, positive colonies were identified by bluewhite selection and propagated in the LB overnight at 37 C. The plasmid was purified from the E. coli using a Mini prep kit. g The direction and sequence of the insert was identified by sequencing using oligonucleotide primers T7 (5Ј-TAA-TACGACTCACTATAGGG-3Ј) and Sp6 (5Ј-GATTTAGGT-GACACTATAG-3Ј). Escherichia coli colonies containing the recombinant plasmid with the correct insert were propagated in the LB, and the plasmid was purified as described above. After digestion of the plasmid with Pst I, competitor RNA (456 bp) was prepared by an in vitro transcription reaction using the T7 primer, a mixture of ribonucleoside triphosphates (NTPs), and T7 RNA polymerase by a commercial Dig RNA-labeling transcription kit, e according to the manufacturer's protocol with slight modifications. The solution of the transcription reaction was treated with RNasefree deoxyribonuclease at 37 C for 20 min. To precipitate the RNA transcripts, 2.0 l of 2 mM ethylenediaminetetraacetic acid pH 8.0, 2.5 l of 4 M lithium chloride, and 80 l absolute ethanol were added and left at Ϫ70 C overnight. The RNA was pelleted down by centrifugation at the speed of 12,000 g for 30 min at 4 C. The pellet was washed with 75 l of 70% cold ethanol and precipitated by centrifugation at 12,000 g for 30 min at 4 C. The resultant pellet was dissolved in RNase free, DEPC-treated ddH 2 O. The amount of resulting competitor RNA was measured using a spectrophotometer at absorbance 260 nm, aliquoted, and stored at Ϫ70 C until used.
Preparation of standard control RNA. Standard control RNA also was produced using similar protocols and reagents as described for the competitor RNA preparation. Using primers H5/H7, 545 bp cDNA was amplified from an ALV-J isolate (ADOL-7501) by RT-PCR and the amplicon was inserted into pGEM-T Easy vector system. The recombinant plasmid was transformed into the same competent JM109 high-efficiency E. coli strain, and the resulting bacterial colonies were screened and prepared by the similar method described for the competitor RNA. Escherichia coli with the plasmid containing the correct insert were identified, propagated, and prepared, as described for the competitor RNA. After digestion of the plasmid with Nco I j for 2 hr at 37 C, standard control RNA (636 bp) was prepared by an in vitro transcription reaction using the SP6 primer, mixture of rNTPs, and SP6 RNA polymerase, as described above for the competitor RNA. After purification, the amount of standard control RNA was measured by spectrophotometry, aliquoted, and stored at Ϫ70 C until used.
Determination of amplification kinetics. Five hundred picograms of standard control RNA was used as a template for determination of the amplification kinetics of the RT-PCR reaction. A one-tube RT-PCR reaction was performed with reverse transcription reaction followed by amplification cycles. The RT-PCR products were collected after 23, 25, 27, 29, 31, 33, and 35 cycles. These products were loaded into separate lanes of a 1.5% agarose gel, ran by electrophoresis, stained by ethidium bromide, the band intensities of the 545-bp complementary DNA (cDNA) product were measured, and plotted against respective cycle numbers.
One-tube QC-RT-PCR. The primers used (H5/H7) were specific for ALV-J. 16 Briefly, serially diluted known amounts of the competitor RNA, which had the same primer-binding sites but produced a different-sized amplification product, were added to each RT-PCR tube containing 1 1 of the total RNAs from the infected-cell lysates with different TCID 50 s. One-tube RT-PCR was carried out using a Titan One-tube RT-PCR system, e as described above. The program consisted of reverse transcription at 42 C for 45 min, 95 C for 5 min, and 31-35 identical cycles of denaturation (94 C for 30 sec), annealing (52 C for 30 sec), extension (72 C for 1 min), followed by an extra 5 min for extension (72 C) at the end of the last cycle. The reaction component was added in reaction tubes to a final volume of 25 l. Final reaction conditions were 0.5 l of enzyme mix and 5 l 5ϫ dilution buffer provided in Titan One-tube RT-PCR system, e 2 mM MgCl 2 , 0.25 mM dNTP mix, 5 mM of primers H5 and H7, 20 U RNase inhibitor, 2.5 mM DTT, and 1 l of sample RNA, and 2 l of serially diluted competitor RNA. Amplified products of QC-RT-PCR were loaded on 1.5% agarose gel, and the band intensities of each product were analyzed using a Geldoc 1000 camera system and Molecular analysis software. k Adjusted intensity of the competitor cDNA was calculated as follows: Corrected band intensity of competitor cDNA ϭ band intensity ϫ (545/369). The ratio of corrected band intensity of 545-bp cDNA products from sample RNAs and that of the corresponding 369-bp cDNA from the competitor RNA was calculated. Then, a regression line was generated using a logarithmic plot of the ratio of intensities and amounts of competitor RNA added in each reaction. The amount of sample RNA was calculated by determining the equivalence point in the regression line, as previously described. 14 
Results
Production of competitor and control RNA. A simplified overview of the protocol for preparation of competitor RNA is shown in Fig. 1 . Products of various steps are shown in Fig. 2 . A fragment of 545-bp cDNA covering portions of int and env genes was produced by RT-PCR using H5/H7 primers as described above. This fragment was digested with 2 different restriction enzymes. Taq I produced 2 fragments (147 and 398 bp), and Aci I produced 3 products (99, 224, and 222 bp). The 147 bp fragment resulting from Taq I restriction and the 222 bp fragment resulting from Aci I treatment were religated, producing a 369 bp product that could be amplified by PCR with H5/H7. This fragment was inserted into the pGEM-T Easy vector system and a 547 cDNA fragment was successfully amplified by PCR reaction with SP6 and T7 primers from the recombinant plasmid (Fig. 2) . The recombinant plasmid with the correct insert was identified by sequencing using SP6 and T7 primers. Sequence data of the insert were identical to the corresponding viral RNA sequence except for the predicted 176 bp deletion in the middle of the fragment (data not shown). In vitro-transcribed competitor RNA (456 bp) was successfully amplified by RT-PCR using primers H5/H7 and produced a 369 bp fragment (Fig. 2) . Standard control RNA (636 bp) was prepared by the in vitro transcription reaction, and a 545 bp fragment was amplified from it by RT-PCR using primers H5/ H7 (data not shown).
Amplification kinetics. Five hundred picograms of standard control RNA was used as a template to determine the amplification kinetics of the one-tube RT-PCR reaction. Plotted amplification curves exhibited a typical sigmoid shape (Fig. 3) . Linear increases in band intensity were observed from 23 to 31 cycles, and no further increases were seen from 33 to 35 cycles.
Quantitative competitive RT-PCR. Total RNA from cell lysates infected with ALV-J (ADOL 7501) was coamplified with the RNA competitor in a one-tube QC-RT-PCR assay to measure RNA levels ( Fig. 4) . No significant increase in sensitivity was observed with 35 cycles: therefore, a 31-cycle program was used for our QC-RT-PCR (data not shown). Progressive competition occurred between fixed amounts of sample RNA and serially diluted competitor RNA. Regression lines for each sample were generated and equivalence points were determined for calculation of viral RNA amounts, as described previously. A regression line (y ϭ 0.9119x Ϫ 2.5293, R 2 ϭ 0.9972) for 1 typical sample is shown in Fig. 5 . At the molar equivalence point the corrected fluorescence of the competitor (369 bp) should equal the measured fluorescence for the sample RNA (545 bp), and their ratio should equal 1. Interpolation on the plot for a y value of 0 (log 10 1 ϭ 0) gave the amount of sample RNA present in each test sample as measured by QC-RT-PCR (Table 1 ). Sensitivity of quantification. The detection limit of QC-RT-PCR was 25 fg as determined by serial 10-fold dilution of standard control RNA from 1 g/l to 1 fg/l (data not shown). The assay could also distinguish 10-fold differences in RNA concentration.
Expected and calculated quantity. To confirm the accuracy of the technique, QC-RT-PCR reactions were performed using serial 10-fold dilutions of standard control RNA produced by a run-off in vitro transcription reaction. Amounts calculated by QC-RT-PCR reactions were plotted against the measured amounts using a spectrophotometer. The regression line showed amounts of RNA calculated by QC-RT-PCR strongly correlated with amounts measured using a spectrophotometer ( Fig. 6 ).
Discussion
Cultivation and conventional methods for ALV-J quantification are time consuming, laborious, and difficult to perform. Furthermore, cultivation systems inherently select for isolates that are capable of in vitro propagation. In addition, commercial antigen-capture ELISA systems lack sensitivity, are not specific for ALV-J, and detect group-specific antigen from other subgroups of exogenous and endogenous ALVs. 7 RT-PCR using the primers H5/H7 is specific for ALV-J, and does not detect other subgroups of exogenous and endogenous ALVs. 16 In this study, it was difficult to handle a RNA competitor during its synthesis, purification, and use because of the ubiquitous presence of RNase. Moreover, the reverse transcription step was a very inefficient process, and the separation of this step from the PCR reaction may lead to significant variation and contamination. And the quantity of proviral DNA may not correlate with disease processes and does not always reflect the pathogenesis or replication of ALV. 4, 6, 15 In addition, quantification of ALV RNA in plasma may be a better measure of infection status than quantification of culturable virus in cell culture systems. Plausible reasons for this have been proposed for HIV-1 RNA. 14 The RT-PCR method is much more sensitive than culture methods, and genomic RNA from total particles including both inactive and intact viral particles may prove to be a better marker of disease status. In addition, the amount of RNA released in the plasma is an indirect measure of the transcriptional status of those infected cells that shed virus. Therefore, the onetube QC-RT-PCR assay for viral RNA was developed in the current study.
A competitor RNA was prepared by in vitro transcription. The sequence of the competitor RNA was identical to cDNA amplified by RT-PCR H5/H7 of ALV-J strain ADOL-7501 except for a 176-bp internal deletion. The size difference allowed differentiation between the PCR products of the competitor and viral RNA. In addition, there was progressive competition between viral RNA and the competitor. In ideal conditions, the number of amplification cycles is not a problem in QC-RT-PCR. However, in practice, it was important that samples be assayed in the exponential phase of the PCR reaction, before the plateau phase. 5 Onset of this plateau phase of the amplification is dependent on the initial amount of template with larger amounts inducing an earlier plateau phase. The amplification kinetics of standard control RNA (500 pg) in an amount larger than the competitor RNA was evaluated by RT-PCR. The 31-cycle program was used for our study because this was the end stage of the exponential phase of amplification for our QC-RT-PCR. Moreover, the 31-cycle amplification showed similar sensitivity to that after 35 cycles.
QC-RT-PCR, which used dilutions of in vitro-transcribed standard control RNA as samples, was performed to verify this newly developed technique. The amounts calculated by QC-RT-PCR were almost identical to the amounts measured by spectrophotometry, indicating that this QC-RT-PCR assay was accurate. The sensitivity of the developed assay was 25 fg of in vitro-transcribed standard RNA, corresponding to 8 ϫ 10 4 copies, and 10-fold differences between samples could be differentiated. Also this assay was strongly correlated with the TCID 50 s determined by classical cell culture systems and commercial ag-ELISA. 11 This new QC-RT-PCR assay was sensitive, accurate, reproducible, and can be used for diagnosis and simultaneous quantification of ALV-J RNA. Furthermore, it can be semiautomated, is relatively simple and easy to perform, and can be completed within 12 hours. The assay as designed was specific for ALV-J and could be modified to quantify other subgroups of ALV. In the future it will be useful for the study of virus replication, control of viral gene expression, and viral pathogenesis.
